Natasha C Moningka

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. pmc Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade
    Natasha C Moningka
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, USA
    Nephrol Dial Transplant 27:913-20. 2012
  2. pmc Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase
    Natasha C Moningka
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL 32610, USA
    Mech Ageing Dev 132:1-7. 2011
  3. pmc Twelve weeks of treadmill exercise does not alter age-dependent chronic kidney disease in the Fisher 344 male rat
    Natasha C Moningka
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL 32610, USA
    J Physiol 589:6129-38. 2011
  4. pmc Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade
    Jennifer M Sasser
    Departments of Physiology and Functional Genomics, University of Florida, Gainesville, FL, USA
    Life Sci 91:54-63. 2012
  5. pmc Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats
    Gin Fu Chen
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, USA
    Nephrol Dial Transplant 25:3518-25. 2010
  6. pmc Arginine and asymmetric dimethylarginine in puromycin aminonucleoside-induced chronic kidney disease in the rat
    Gin Fu Chen
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, USA
    Am J Nephrol 35:40-8. 2012
  7. pmc Sexual dimorphism in development of kidney damage in aging Fischer-344 rats
    Jennifer M Sasser
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, USA
    Gend Med 9:219-31. 2012
  8. pmc Asymmetric dimethylarginine in angiotensin II-induced hypertension
    Jennifer M Sasser
    Dept of Physiology and Functional Genomics, University of Florida, Gainesville, FL 32610, USA
    Am J Physiol Regul Integr Comp Physiol 298:R740-6. 2010

Detail Information

Publications8

  1. pmc Protective actions of nebivolol on chronic nitric oxide synthase inhibition-induced hypertension and chronic kidney disease in the rat: a comparison with angiotensin II receptor blockade
    Natasha C Moningka
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, USA
    Nephrol Dial Transplant 27:913-20. 2012
    ..The β-blocker, nebivolol (N), also enhances NO production, and we studied whether N attenuates CKD and hypertension caused by chronic NO synthase inhibition (CNOSI)...
  2. pmc Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase
    Natasha C Moningka
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL 32610, USA
    Mech Ageing Dev 132:1-7. 2011
    ..The tubulointerstitial injury seen with aging is reversed with 6 months of ARB but not ACEI and is not associated with renal NOS...
  3. pmc Twelve weeks of treadmill exercise does not alter age-dependent chronic kidney disease in the Fisher 344 male rat
    Natasha C Moningka
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL 32610, USA
    J Physiol 589:6129-38. 2011
    ..Data indicate that exercise-induced increases in eNOS and EC SOD seen in young rats are lost with age. We conclude that chronic exercise is ineffective in reversing age-dependent CKD in the male F344 rat...
  4. pmc Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade
    Jennifer M Sasser
    Departments of Physiology and Functional Genomics, University of Florida, Gainesville, FL, USA
    Life Sci 91:54-63. 2012
    ..Here, we investigated whether Nebivolol attenuates hypertension and renal injury after 5/6 ablation/infarction (A/I). Efficacy was compared to the AT1 receptor antagonist Olmesartan...
  5. pmc Effects of angiotensin type 1 receptor blockade on arginine and ADMA synthesis and metabolic pathways in fawn-hooded hypertensive rats
    Gin Fu Chen
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, USA
    Nephrol Dial Transplant 25:3518-25. 2010
    ..L-Arg is then taken up from plasma into cells where it can be utilized by NOS and other pathways. The competitive inhibitor of NOS, ADMA, is degraded by dimethylarginine dimethylaminohydrolase (DDAH)...
  6. pmc Arginine and asymmetric dimethylarginine in puromycin aminonucleoside-induced chronic kidney disease in the rat
    Gin Fu Chen
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, USA
    Am J Nephrol 35:40-8. 2012
    ..This study investigated pathways of L-Arg synthesis/uptake/utilization, ADMA degradation and oxidant/antioxidants in puromycin aminonucleoside (PAN) chronic kidney disease (CKD)...
  7. pmc Sexual dimorphism in development of kidney damage in aging Fischer-344 rats
    Jennifer M Sasser
    Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, USA
    Gend Med 9:219-31. 2012
    ..Aging kidneys exhibit slowly developing injury and women are usually protected compared with men, in association with maintained renal nitric oxide...
  8. pmc Asymmetric dimethylarginine in angiotensin II-induced hypertension
    Jennifer M Sasser
    Dept of Physiology and Functional Genomics, University of Florida, Gainesville, FL 32610, USA
    Am J Physiol Regul Integr Comp Physiol 298:R740-6. 2010
    ..However, the presence of renal injury and sustained hypertension for 6 wk increases ADMA levels and contributes to nitric oxide deficiency and cardiovascular disease...